Transforming Vaccine Science into Regulatory Success
What I Offer
Immunology-led Trial Design — I craft studies that measure robust immune responses, harnessing the right biomarkers, assays, and endpoints to support both efficacy and safety objectives.
Regulatory Strategy & IND/BLA Submission — I prepare compelling IND (Investigational New Drug) applications and guide you through Biologics License Applications (BLA), utilizing my deep understanding of FDA standards and pathways.
Operational Excellence in Clinical Phases — From Phase I (safety/dose escalation) through Phase III (efficacy), I lead trial implementation, risk mitigation, and quality assurance rooted in GCP and regulatory best practices.
FDA Interaction & Advisory Readiness — Whether preparing for IND consultations, Advisory Committee briefings, or responding to FDA queries, I serve as your trusted liaison.
Post-Approval Surveillance & Phase IV Monitoring — I help design and execute post-marketing studies and safety surveillance plans, ensuring long-term efficacy and safety while maintaining public trust.
Key Benefits
Decades of Proven Expertise: My foundation in vaccine science and trial management offers both depth and trust.
Seamless Integration of Science and Strategy: I leverage immunology insights to inform regulatory checkpoints and clinical decisions.
Full Lifecycle Support: From immune response planning to licensure and beyond, I ensure continuity and cohesion.
Global Trial Leadership: I’ve successfully managed trials across multiple African sites, aligning local needs with international regulatory standards.
1. What role does immunology play in trial design?
Immunology defines the "what to measure" and "why it matters." I help select meaningful biomarkers, immune assays, and timing protocols that align with regulatory expectations and accelerate approval.
2. What documents will you prepare for the IND?
I’ll deliver a complete set: immunogenicity assays, preclinical validation, clinical protocol, investigator brochures, safety data, informed consent forms... everything the FDA expects for IND review.
3. Can you support adaptive or expedited trials?
Absolutely—I specialize in designing flexible trial frameworks, including adaptive designs and fast-track pathways where appropriate, optimizing for both regulatory alignment and practical efficiencies.
4. How do you manage multi-country trials?
I coordinate across diverse regulatory environments, ensuring compliance with both local and FDA standards—leveraging established networks and a track record of successful multi-site trial operations across Africa.
5. How do you ensure FDA inspections or audits go smoothly?
I build inspection-ready documentation and train site personnel rigorously. That prep ensures your trial’s data integrity and operational compliance withstand inspection scrutiny.
Let’s Bring Your Vaccine to Approval
If you're aiming to reach FDA approval with scientific rigor and operational clarity, I can lead the way. Book a consultation today to map out your vaccine’s development journey.